Try this thought...ResMed pay $20 M licence fee to RAP for rights to the sleep Apnea app. That $20 M triggers the 94 M bonus shares and drives the SP to $7.50 and negates any T/O bid...unless it is north of $10. Just a thought. The quickest way to bonus 94 M shares is to lock that down with an exclusive deal to ResMed and pick themselves up $650 M in shares. That is what I would be striving for. Cash in the bag, bonus shares, shite loads of (quota) testing dollars coming in at a discounted $35 each and the cough tech still to come. Monster in the making IMHO so DYOR (lol) should you feel the need.
- Forums
- ASX - By Stock
- RAP
- Ann: Positive Results from At-Home Sleep Apnoea Study
Ann: Positive Results from At-Home Sleep Apnoea Study, page-93
-
- There are more pages in this discussion • 48 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAP (ASX) to my watchlist
(20min delay)
|
|||||
Last
20.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $176.2M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
RAP (ASX) Chart |
Day chart unavailable